多模态影像技术在非小细胞肺癌免疫治疗中的应用进展  

Advances in Multimodal Imaging Techniques for Immunotherapy of Non-small Cell Lung Cancer

作　　者：陈思远 鄂林宁 王荣华 CHEN Siyuan;E Linning;WANG Ronghua(College of Medical Imaging,Shanxi Medical University,Taiyuan 030001,China;Department of Radiology,Shanxi Bethune Hospital,Shanxi Academy of Medical Sciences,Taiyuan 030032,China)

机构地区：[1]山西医科大学医学影像学院,太原030001 [2]山西白求恩医院(山西医学科学院)放射科,太原030032

出　　处：《CT理论与应用研究(中英文)》2025年第2期333-338,共6页Computerized Tomography Theory and Applications

基　　金：中央引导地方科技发展资金(基于CT-DLR技术联合病理大切片的肺癌免疫状态预测研究(YDZJSX2022A068))。

摘　　要：随着肿瘤免疫治疗方法的出现,非小细胞肺癌(NSCLC)的免疫状态与治疗方案的选择密切相关,治疗前通过有效手段筛选获益人群至关重要。多模态影像技术具有无创、全面、可重复等优势,在NSCLC患者的免疫状态、早期治疗评估及远期疗效预测等方面具有重要价值。本文旨在对CT、MRI及PET/CT在NSCLC免疫治疗中的应用进展进行综述。With the emergence of tumor immunotherapy,the immune status of non-small cell lung cancer(NSCLC) is closely linked to treatment selection.Therefore,it is crucial to identify potential beneficiaries using effective methods prior to treatment.Multimodal imaging techniques are advantageous as they are non-invasive,comprehensive,and repeatable,making them valuable for assessing immune status,evaluating early treatment,and predicting long-term outcomes in NSCLC patients.This article aims to review the progress in the application of CT,MRI and PET/CT in NSCLC immunotherapy.

关 键 词：非小细胞肺癌 多模态成像 肿瘤微环境 免疫疗法 

分 类 号：R814[医药卫生—影像医学与核医学] R445[医药卫生—放射医学]